Skip to main content
Clinical Trials/NL-OMON39036
NL-OMON39036
Completed
Phase 4

A randomized controlled trial on the effects of periconceptional and prenatal folic acid supplementation on congenital anomalies and preterm birth - Folic acid Extra

Vrije Universiteit Medisch Centrum0 sites5,000 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
spina bifida/myelomeningocele
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
5000
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • All women living in the Northern region of the Netherlands of 18 to 45 years old who want to become pregnant within 12 months are eligible for participation in the study.

Exclusion Criteria

  • Women who had previous offspring with NTD and other women who take high doses of FA for any other reason and women who use FA\-antagonists will be excluded from the study.
  • Further exclusion criteria are:
  • a) no informed consent given
  • b) not understanding Dutch
  • c) already pregnant at time of inclusion or within 4 weeks after start intervention
  • d) planning to move to an area where the study is not implemented
  • e) recently or at present using folic acid antagonists or antifolates or other drugs influencing the folic acid metabolism (methotrexaat, pyrimethamine, trimethoprim)
  • f) being affected by diabetes, megaloblastic anaemia and/or cancer (previous cancer or abnormal PAP smears)
  • g) being allergic to folic acid or any other ingredient of the pills used in this study
  • h) take defined dosages of folic acid for directions other than those listed in the above exclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials